168 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
11 Jun 24
Departure of Directors or Certain Officers
4:15pm
the U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA”), maintained for a select group of management or highly compensated … participation in, or benefits accrued under, any Company employee benefit plan or arrangement, which amounts shall be payable in accordance with the terms
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
15 May 24
Adaptimmune Reports Q1 2024 Financial and Business Updates
7:39am
in the three months ended March 31, 2024 increased in employee-related costs and additional costs associated with lease properties following
8-K
EX-10.1
bnw21ke
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
8-K
leuqk7 6bq
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
S-8
cwerw
30 Nov 23
Registration of securities for employees
4:16pm
S-8
cb63adcj fn
30 Nov 23
Registration of securities for employees
4:16pm
S-8
EX-5.1
wi5zawu 9oiub8hl8
30 Nov 23
Registration of securities for employees
4:16pm
S-8 POS
2c3yslxqnhgg0z ag
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:54pm
S-8 POS
42li3j
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:48pm
8-K
5ee1ykj j5n
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.2
h51bywihudc07l
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
vtvq1g8g
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.4
jly5vcgb w0jq
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.3
zwx 2auvr
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm